Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., . . . Merad, M. (2016). Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity.

Salmon, Hélène, et al. "Expansion and Activation of CD103(+) Dendritic Cell Progenitors At the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition." Immunity 2016.

Salmon, Hélène, et al. "Expansion and Activation of CD103(+) Dendritic Cell Progenitors At the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition." Immunity 2016.